Suggested Resources

For further reading, we suggest the following resources, organized by topic:

The Sustainability Problem

ECON Centre for Economic Analysis. 2006. Developing benchmarks for financing immunization. Report 25/03 Commissioned by the Bill & Melinda Gates Foundation.

Kaddar M, Furrer E. 2009. Are current debt relief initiatives an option for scaling up health financing in beneficiary countries? Bulletin of the World Health Organization. Volume 86, Number 11, November, 817-908

Lydon P, Beyai PL, Chaudry I, Cakmak N, Satoulou A, Dumolard L. 2008. Government financing for health and specific national budget lines: The case of vaccines and immunization. Vaccine. In press.

Lydon P. 2006. Immunization Financing Analysis. A look across 50 GAVI countries. Unpublished paper. Geneva: Department of Immunizations, Vaccines and Biologicals, World Health Organization.

Peny JM, Gleizes O, Covilard JP. 2005. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective. Vaccine. 2005 Aug 31;23(37):4610-8.

Scheiber, G, C Baeza, D Kress, Maier M. 2006. Financing Health Systems in the 21st Century. In Jamison et al., eds. Disease Control Priorities in Developing Countries. Second Edition. Washington, DC: The World Bank: 225-242.

World Health Organization. 2006. The cost of immunization programmes in the next 10 years.

Immunization Strategies

Centers for Disease Control and Prevention (CDC). 2006. Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015. MMWR. May 12;55(18):511-5.

GAVI Alliance. Country progress reports and recommendations.

World Health Organization. 2006. WHO-UNICEF guidelines for preparing a multi-year plan (cMYP). Expanded Programme on Immunization of the Department of Immunization, Vaccines and Biologicals. Document WHO/IVB/05.20.

World Health Organization and UNICEF. 2005. Global Immunization Vision and Strategy 2006-2015. Geneva: Department of Immunizations, Vaccines and Biologicals, World Health Organization.

Civil Society

Agerskov, Anders Hjorth. 2005. Global Public Goods and Development – A Guide for Policy Makers. Seminar No. 6: Global Development Challenges Facing Humanity. World Bank Seminar Series at Kobe and Hiroshima Universities.

GAVI. 2007. Enhancing civil society participation in GAVI Alliance governance and programme implementation 2007-2008 . Background Paper Doc. A2, 19th GAVI Alliance Board Meeting, 29 November 2006 (prepared by Allan Bass).

Russel-Einhorn M. Legal and Institutional Frameworks Supporting Accountability in Budgeting and Service Delivery Performance. In Shah A, ed. Performance Accountability and Combating Corruption. Washington, DC: The World Bank, 2007: 183-232.

The Economics of Immunization

Bloom D, Canning D, Weston M. 2005. The value of vaccination. World Economics, 6(3): 15-40.

Brenzel L, Wolfson LJ, Fox-Rushby J, Miller M, Halsey, NA. 2006. Vaccine-Preventable Diseases. In: Jamison et al. (eds): Disease Control Priorities in Developing Countries. Second Edition. Washington, DC: The World Bank, 389-411.

Fox-Rushby JA, Kaddar M, Levine R, Brenzel L. 2004. The economics of vaccination in low- and middle-income countries. Bulletin of the World Health Organization, 82:640.

Kaul I, Faust M. 2001. Global public goods and health: taking the agenda forward . Bulletin of the World Health Organization, 79: 869–874.

Uzicanin A, Zhou F, Eggers R, Webb E, Strebel P. 2004. Economic analysis of the 1996–1997 mass measles immunization campaigns in South Africa. Vaccine, 22(25–26): 3419–26

Wolfson LJ, Gasse F, Lee-Martin S, Lydon P, Magan A, Tibouti A, Johns B, Hutubessy R, Salama P, Okwo-Bele, J. 2008. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bulletin of the World Health Organization, 86(1): 27-39.

Parliaments

Hudson A, Wren C (Overseas Development Institute.) 2007. Parliamentary strengthening in developing countries (report prepared for DFID).

Mataure M. 2003. Parliamentary Functions and Reforms and their application in promoting Health Equity in Southern Africa. Unpublished paper. Southern African Regional Network for Equity in Health (EQUINET).

General

Khan MM, Ehreth J. 2003. Costs and benefits of polio eradication: a long-run global perspective. Vaccine, 21(7-8):702-5.

Matthews Z, Diamond I. 1999. The Expanded Programme on Immunisation: mortality consequences and demographic impact in developing countries. Genus, 55: 73–100.

Pigman, H. 2005. Conquering Polio. Evanston, IL: The Rotary Foundation.

Shearley AE. 1999. The societal value of vaccination in developing countries. Vaccine, 17: S109-S112.

Thompson KM, Radboud J, Tebbens D. 2007. Eradication versus control for poliomyelitis: an economic analysis. Lancet, 369(9570):1363-1371.

World Health Organization. 2006. WHO vaccine-preventable diseases: monitoring system 2006 global summary . (WHO/IVB/2006). Geneva: Immunization, Vaccines and Biologicals.

World Health Organization, UNICEF, World Bank. State of the world’s vaccines and immunization, 3rd ed. Geneva, World Health Organization, 2009.